Oral Cancer Screening
|
Our patients rely on us to be an expert in oral health. Dentists and hygenists are the best overall defense against oral cancer -- we are, in fact, a lifesaver. No other medical professionals are as well positioned to address this potentially deadly disease at its earliest stage. The key is to identify oral abnormalities at their most easily treated stage of development.
Fortunately, there's a simple technology to help in your fight against oral cancer. ViziLite Plus aids in the early identification of oral abnormalities that can lead to cancer. Cleared by the FDA, ViziLite Plus allows dentists to offer superior care to patients. Annual ViziLite Plus exams can be integrated with exsisting patient services, improving patient care and creating a positive financial impact in dental practices. How ViziLite Plus Works ViziLite Plus with TBlue630 is an oral lesion identification and marking system that is used as an adjunct to the conventional head and neck examination. It is comprised of a chemiluminescent light source (ViziLite) to improve the identification of lesions and a blue phenothiazine dye to mark those lesions identified by ViziLite. ViziLitePlus with TBlue630 is designed to be used in a patient population at increased risk for oral cancer. Below is an image of Squamous cell carcinoma – identified and stained with ViziLite TBlue |
What you see under normal light What you see using ViziLite Plus
|
Welcome /Mission Statement/ About Dr. Adlow / Our Practice / Procedures / Special Services / Contact Us
Steven J Adlow DDS - Where Art and Dentistry Come Together
